SCHEMBL4826549

SCHEMBL4826549

O=C1C2C(C(=O)N1OS(=O)(=O)c1cccc(C(F)(F)F)c1)C1C(=O)N(OS(=O)(=O)c3cccc(C(F)(F)F)c3)C(=O)C21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP13 P45452 1/20 0.47
AKR1B1 P15121 1/20 0.42
HTT P42858 1/20 0.41
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
AR P10275 1/20 0.40
ESR2 Q92731 1/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PARL Q9H300 1/20 0.40
CACNA1B Q00975 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3830355 0.92 CA1 (0.43) CA1CA2MMP1MMP2MMP9
SCHEMBL4826369 0.88 CA1 (0.43) CA1CA2MMP1MMP2MMP9
SCHEMBL4831781 0.86 CES2 (0.36) CA1CA2MMP1MMP2MMP9
SCHEMBL4831892 0.82 KMT2A (0.43) CA1CA2AKR1B1KMT2APARL
SCHEMBL6424823 0.78 GAA (0.33) KMT2APARLPOLBALDH1A1KDM4E
SCHEMBL4831893 0.78 PKM (0.32) CA1CA2MMP1MMP2MMP9
SCHEMBL3824037 0.77 CA1 (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL4829803 0.76 PARL (0.65) HTTKMT2ALMNAPARLPOLB
SCHEMBL31425773 0.76 CA1 (0.59) CA1CA2MMP1MMP2MMP9
SCHEMBL3822658 0.76 KMT2A (0.48) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US claimed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP claimed
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 CA1 603/4885CA2 1249/4885MMP1 4672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.